Skip to main content
. Author manuscript; available in PMC: 2011 Jan 21.
Published in final edited form as: Invest New Drugs. 2008 Oct 22;27(5):469–475. doi: 10.1007/s10637-008-9190-8

Table 3.

Response (N = 25)

  Complete Response 0 0%
  Partial Response 0 0%
  Unconfirmed Complete Response 0 0%
  Unconfirmed Partial response 0 0%
  Stable/No Response 4 16%
  Increasing Disease 17 68%
  Symptomatic Deterioration 3 12%
  Assessment Inadequate 1 4%
Total 25 100%